ABVC BioPharma, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2010
Total Assets: $293.9K
Liabilities Breakdown FY2010
Total Liabilities: $3.3M
Asset Breakdown
Total Assets: $293.9K
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.8K | 1.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $41.9K | 14.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $249.2K | 84.8% |
Liabilities Breakdown
Total Liabilities: $3.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $989.5K | 30.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $2.3M | 69.9% |